Today: 19 May 2026
Intuit stock price jumps on Anthropic AI deal as earnings loom — what investors watch Thursday

Intuit stock price jumps on Anthropic AI deal as earnings loom — what investors watch Thursday

New York, February 26, 2026, 05:26 EST — Premarket

  • Intuit finished Wednesday with shares up roughly 6.3%, rebounding to $381.23.
  • Anthropic’s partnership brought fresh attention to AI strategy, just as results are set to land after the bell.
  • Investors want to see guidance, get a read on product demand, and spot any tangible AI payoff.

Intuit Inc (INTU.O) popped roughly 6.3% in the previous session, finishing at $381.23 and drawing new attention in Thursday’s U.S. premarket action. Shares moved in a $353.53-to-$381.59 range for the day, with volume reaching around 5.3 million trades.

Timing’s key here. Software shares have swung sharply, as worries mount that generative AI might threaten subscription models—even as the broader market fights for stability. “Investors are trying to grapple with what could potentially be existential risk,” said Zach Hill, head of portfolio management at Horizon Investments. A tech-driven Wall Street rally on Wednesday, highlighted by Reuters, is setting up a tough spotlight for upcoming results from names such as Intuit. Reuters

Software stocks attracted bargain hunters earlier this week, following a flurry of new enterprise products and partnerships from AI shop Anthropic. “We feel positive to see companies partnering with Anthropic,” North Star Investment Management Corp’s chief investment officer Eric Kuby remarked, as attention moved from talk of disruption to the question of monetizing AI. Reuters

Intuit said Tuesday it’s teaming up with Anthropic in a multi-year deal to develop AI “agents”—software designed to automate tasks for mid-market clients—on Intuit’s platform, leveraging Anthropic’s Claude technology. The company added it plans to integrate features from TurboTax, Credit Karma, QuickBooks, and Mailchimp directly into Anthropic’s products. Intuit CTO Alex Balazs called it “a groundbreaking partnership,” according to the statement. Intuit Inc.

Anthropic, which counts Alphabet’s Google and Amazon.com among its backers, has been rolling out a string of new “plug-ins” that link its Claude AI with widely used business apps. According to the company, its latest batch brought on board FactSet, Salesforce’s Slack, and DocuSign. Shares in several of those firms ticked higher after the announcement, Reuters noted. “It’s not a product that’s trying to own every workflow,” said Scott White, Anthropic’s head of product for enterprise. Reuters

Despite Wednesday’s rally, Intuit’s shares are still deep in the red. Reuters Breakingviews notes the stock has fallen 46% so far this year, tracking the broader swoon that’s dragged the BVP Nasdaq Emerging Cloud Index down 25% in 2024.

Price targets in the sector keep slipping. Wells Fargo trimmed its call on Intuit, slashing the target to $425 from $700 while sticking with an equal-weight rating, according to MT Newswires.

Thursday’s report puts Intuit on the spot: investors want to see hard numbers. Focus points? Small-business accounting, tax filing, Credit Karma’s marketplace activity. Management’s comments on AI spending—and whether that’s driving revenue or customer retention—will be scrutinized closely.

The risk remains. Any hint of caution or vague optimism can erase gains in a hurry, as traders recently hammered software names touting AI without proof it shields pricing, margins, or growth. When financial data gets pulled in, privacy and compliance concerns start breathing down the necks of these products.

Intuit will release its fiscal second-quarter earnings after Thursday’s closing bell, with a conference call set for 1:30 p.m. Pacific. Where the stock heads next will probably hinge on updated guidance and concrete details about the company’s latest AI initiatives.

Stock Market Today

  • German Government Starts Privatization of Uniper SE Energy Firm
    May 19, 2026, 2:22 AM EDT. Germany has initiated the privatization process for energy provider Uniper SE, signaling a potential major shift in Europe's energy sector. This move opens the door to what could become the continent's largest utility deal in 2024. The German government aims to reduce its stake in the company, inviting private investors to participate. Uniper, a key player in energy supply, has been under state control following financial strains during recent market volatility. The privatization marks a strategic step towards market normalization and increased private sector involvement in the energy industry.

Latest articles

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

19 May 2026
Dominion Energy shares jumped 9.4% after agreeing to an all-stock merger with NextEra Energy, whose shares fell 4.6%. The S&P 500 slipped 0.1% and the Nasdaq dropped 0.5% as investors sold technology stocks amid rising Treasury yields and oil prices. Nvidia fell 1.4% ahead of earnings. U.S. crude settled at $107.37, and the 10-year Treasury yield reached 4.59%.
XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

19 May 2026
XP Inc.’s U.S.-listed shares fell 3.78% in after-hours trading Monday after reporting higher Q1 profit but weaker net inflows and a lower retail take rate. Net income rose 7% to 1.32 billion reais, but net inflow dropped to 14 billion reais from 24 billion a year earlier. The company declared a $0.20 dividend and announced a new CFO, Gustavo Alejo Viviani, starting August 3.
LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

19 May 2026
Publicis Groupe agreed to buy LiveRamp Holdings for $38.50 a share in cash, valuing the U.S. data-collaboration firm at $2.546 billion. LiveRamp stock jumped to $37.77 on the news, while the broader market fell. LiveRamp reported fiscal Q4 revenue of $206 million, up 9% from a year earlier. Publicis said the deal will boost its adjusted earnings per share from the first year after closing.

Popular

Regeneron stock sinks after cancer trial miss prompts selloff

Regeneron stock sinks after cancer trial miss prompts selloff

19 May 2026
Regeneron Pharmaceuticals shares fell 9.8% to $629.68 Monday after its late-stage melanoma drug trial with fianlimab failed to meet the main goal. The study did not show a statistically significant benefit over Merck’s Keytruda. At least 10 brokerages cut price targets. The decline outpaced broader market losses, with the Nasdaq down 0.5%.
Lloyds share price edges up as buyback rolls on and BoE rate-cut bets sharpen
Previous Story

Lloyds share price edges up as buyback rolls on and BoE rate-cut bets sharpen

Nu Holdings (NU) stock slips in premarket as Nubank earnings spark fresh cost worries
Next Story

Nu Holdings (NU) stock slips in premarket as Nubank earnings spark fresh cost worries

Go toTop